PUBLISHER: The Business Research Company | PRODUCT CODE: 1946644
PUBLISHER: The Business Research Company | PRODUCT CODE: 1946644
Oncology devices are specialized medical devices utilized for the diagnosis, management, and treatment of cancer.
The primary device categories within the field of oncology devices include brachytherapy devices and endoscopic devices. Endoscopic devices serve a critical role in the diagnosis, management, and treatment of cancer by allowing healthcare professionals to visually inspect the internal body cavities and organs for abnormalities. These devices find applications in various cancer therapies, including chemotherapy, hormone therapy, biotherapy/immunotherapy, and radiation therapy. They are employed by a range of end-users, including hospitals, cancer research institutes, and other medical facilities dedicated to cancer care and research.
Tariffs are influencing the oncology devices market by increasing costs of imported imaging systems, radiation therapy equipment, endoscopic devices, precision components, and electronic subsystems used in cancer diagnosis and treatment. Hospitals and cancer centers in North America and Europe are most affected due to reliance on imported high-end oncology equipment, while Asia-Pacific faces pricing pressure on equipment manufacturing and exports. These tariffs are increasing capital investment requirements and slowing technology upgrades. However, they are also encouraging domestic manufacturing, localized assembly of oncology systems, and innovation in cost-efficient cancer care technologies.
The oncology devices market research report is one of a series of new reports from The Business Research Company that provides oncology devices market statistics, including oncology devices industry global market size, regional shares, competitors with a oncology devices market share, detailed oncology devices market segments, market trends and opportunities, and any further data you may need to thrive in the oncology devices industry. This oncology devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The oncology devices market size has grown rapidly in recent years. It will grow from $177.72 billion in 2025 to $210.15 billion in 2026 at a compound annual growth rate (CAGR) of 18.2%. The growth in the historic period can be attributed to increasing global cancer incidence rates, expansion of hospital oncology departments, growing demand for early diagnosis technologies, availability of advanced imaging systems, rising awareness of cancer screening programs.
The oncology devices market size is expected to see rapid growth in the next few years. It will grow to $397.27 billion in 2030 at a compound annual growth rate (CAGR) of 17.3%. The growth in the forecast period can be attributed to increasing adoption of personalized cancer treatment devices, rising investments in oncology infrastructure, expansion of outpatient cancer treatment facilities, growing use of AI-driven diagnostic tools, increasing focus on precision oncology solutions. Major trends in the forecast period include increasing adoption of advanced cancer diagnostic devices, rising use of image-guided oncology therapies, growing integration of minimally invasive cancer treatment tools, expansion of precision radiation therapy equipment, enhanced focus on early cancer detection.
The growing demand for chemotherapy is anticipated to drive the expansion of the oncology devices market in the coming years. Chemotherapy is a cancer treatment that involves the use of potent drugs to eliminate rapidly dividing cells, thereby slowing or halting tumor growth and spread. The rising demand for chemotherapy is driven by the increasing global incidence of cancer, as a higher number of diagnosed cases leads to greater need for effective and widely available treatments capable of addressing various cancer types and stages. Oncology devices support chemotherapy by facilitating safer and more accurate drug delivery and monitoring, which improves treatment efficacy and patient outcomes. For example, in January 2025, according to the U.S. National Cancer Institute, a U.S.-based federal cancer research agency, new cancer cases in the United States are projected to reach 2.04 million, up from 1.96 million in 2023, underscoring the growing need for chemotherapy administration systems. Therefore, the rising demand for chemotherapy is contributing to the growth of the oncology devices market.
Major companies operating in the oncology devices market are concentrating on the development of advanced, precision-oriented solutions to enhance treatment accuracy, patient safety, and clinical workflow efficiency. These innovations focus on minimally invasive technologies, improved visualization, and real-time therapy optimization to support better outcomes across a wide range of cancer types. For example, in April 2025, ZEISS, a Germany-based medical technology company, obtained FDA 510(k) clearance for its INTRABEAM 700 system, a next-generation robotic-assisted intraoperative radiotherapy (IORT) platform intended for targeted radiation delivery in neuro-oncology and breast cancer procedures. The system provides increased precision, optimized ergonomics, and improved integration into surgical workflows, allowing clinicians to deliver localized radiation during surgery while reducing exposure to surrounding healthy tissue. By integrating advanced imaging, robotics, and treatment-planning capabilities, the INTRABEAM 700 improves therapeutic accuracy, enables faster clinical decision-making, and supports the industry's transition toward technologically sophisticated, patient-focused oncology care.
In March 2024, Halma PLC, a UK-based company specializing in life-saving technologies that prevent injuries, save lives, and protect people and assets, acquired Rovers Medical Devices B.V. for $93.5 million. This acquisition is intended to expand Halma PLC's market presence in women's health and enhance its capabilities in cancer diagnostics. Rovers Medical Devices B.V. is a Netherlands-based company focused on designing, developing, and manufacturing medical devices for cancer screening.
Major companies operating in the oncology devices market are Eckert & Ziegler BEBIG GmbH, Oncura Inc., GE Healthcare, Medtronic plc, Varian Medical Systems Inc., Elekta AB, Theragenics Corporation, Accuray Incorporated, Roche Diagnostics, IBA Group, Biogenex Laboratories, Becton Dickinson and Company, Siemens Healthineers, Philips Healthcare, Hologic Inc., IBA AG, ViewRay Inc., Canon Medical Systems Corporation, Brainlab, PerkinElmer, RaySearch Laboratories, Mevion Medical Systems, Vision RT, IsoRay, RefleXion Medical, Alpha Tau Medical, Nanobiotix, Mirada Medical Ltd., Navidea Biopharmaceuticals Inc.
North America was the largest region in the oncology devices market in 2025. Asia-Pacific was the second-largest region in the oncology devices market report. The regions covered in the oncology devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the oncology devices market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
The oncology devices market consists of sales of brachytherapy devices and endoscopic devices. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Oncology Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses oncology devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for oncology devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The oncology devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.